BRAF and melanoma: In one study, KDs accelerated tumor growth in a BRAF mutant melanoma mouse model, whereas the growth of NRAS mutant and BRAF wild-type melanomas remained unaffected, suggesting that the tumor genetic background might determine KD responsiveness [4].